| scholarly article | Q13442814 |
| P50 | author | Eóin N McNamee | Q42582545 |
| Edwin F de Zoeten | Q57345364 | ||
| P2093 | author name string | Glenn T Furuta | |
| Kelley E Capocelli | |||
| James J Lee | |||
| Rachel Harris | |||
| Joanne C Masterson | |||
| Paul Jedlicka | |||
| Cheryl Protheroe | |||
| Lindsay Hosford | |||
| Shahan D Fernando | |||
| Kathryn Biette | |||
| P2860 | cites work | Mouse and human eosinophils degranulate in response to platelet-activating factor (PAF) and lysoPAF via a PAF-receptor-independent mechanism: evidence for a novel receptor | Q24629279 |
| A novel IL-1 family cytokine, IL-33, potently activates human eosinophils | Q24647672 | ||
| Human eosinophils express and release IL-13 following CD28-dependent activation | Q28207371 | ||
| IL-13 signaling through the IL-13alpha2 receptor is involved in induction of TGF-beta1 production and fibrosis | Q28285105 | ||
| Interleukin-33 enhances adhesion, CD11b expression and survival in human eosinophils | Q28292740 | ||
| Epithelial-derived IL-33 and its receptor ST2 are dysregulated in ulcerative colitis and in experimental Th1/Th2 driven enteritis | Q30434426 | ||
| Human eosinophil major basic protein is an endogenous allosteric antagonist at the inhibitory muscarinic M2 receptor | Q33894905 | ||
| Activation of eosinophils interacting with dermal fibroblasts by pruritogenic cytokine IL-31 and alarmin IL-33: implications in atopic dermatitis | Q34137362 | ||
| Risk factors associated with progression to intestinal complications of Crohn's disease in a population-based cohort | Q34175981 | ||
| Inflammatory bowel disease-associated interleukin-33 is preferentially expressed in ulceration-associated myofibroblasts. | Q34358060 | ||
| IL-13 promotes collagen accumulation in Crohn's disease fibrosis by down-regulation of fibroblast MMP synthesis: a role for innate lymphoid cells? | Q34540573 | ||
| IL-33 promotes ST2-dependent lung fibrosis by the induction of alternatively activated macrophages and innate lymphoid cells in mice | Q34647885 | ||
| Emergence of fibroblasts with a proinflammatory epigenetically altered phenotype in severe hypoxic pulmonary hypertension | Q35175427 | ||
| CCR3 Blockade Attenuates Eosinophilic Ileitis and Associated Remodeling. | Q35475346 | ||
| Incidence of stricturing and penetrating complications of Crohn's disease diagnosed in pediatric patients. | Q35673366 | ||
| IL-33 induces IL-13-dependent cutaneous fibrosis | Q82370239 | ||
| Interleukin-13 and transforming growth factor β synergise in the pathogenesis of human intestinal fistulae | Q83355378 | ||
| IL-33 Exacerbates Eosinophil-Mediated Airway Inflammation | Q84698017 | ||
| Modulation of IL-33/ST2 system in postinfarction heart failure: correlation with cardiac remodelling markers | Q87895868 | ||
| Ultrastructural features of eosinophilic oesophagitis: impact of treatment on desmosomes | Q35864150 | ||
| Eosinophil-mediated signalling attenuates inflammatory responses in experimental colitis | Q35891878 | ||
| Eosinophilic esophagitis: epithelial mesenchymal transition contributes to esophageal remodeling and reverses with treatment. | Q35923340 | ||
| Opposing roles for IL-13 and IL-13 receptor alpha 2 in health and disease | Q35951827 | ||
| Epithelial exposure to hypoxia modulates neutrophil transepithelial migration | Q36367344 | ||
| Cytokines mediating the induction of chronic colitis and colitis-associated fibrosis | Q36905414 | ||
| Human eosinophils constitutively express multiple Th1, Th2, and immunoregulatory cytokines that are secreted rapidly and differentially | Q37062148 | ||
| Human basophils and eosinophils are the direct target leukocytes of the novel IL-1 family member IL-33. | Q37100750 | ||
| Novel model of TH2-polarized chronic ileitis: the SAMP1 mouse. | Q37206843 | ||
| Intestinal fibrosis in inflammatory bowel disease: progress in basic and clinical science | Q37214366 | ||
| CT imaging features of eosinophilic colitis in children | Q37275429 | ||
| Interleukin-33 overexpression is associated with liver fibrosis in mice and humans. | Q37311036 | ||
| Neutralisation of the interleukin-33/ST2 pathway ameliorates experimental colitis through enhancement of mucosal healing in mice | Q37345931 | ||
| Interleukin-33 potentiates bleomycin-induced lung injury | Q37596499 | ||
| T-helper 2 cytokines, transforming growth factor β1, and eosinophil products induce fibrogenesis and alter muscle motility in patients with eosinophilic esophagitis. | Q37710944 | ||
| Genetics of childhood-onset inflammatory bowel disease | Q37788639 | ||
| A novel histologic scoring system to evaluate mucosal biopsies from patients with eosinophilic esophagitis | Q38422089 | ||
| Intracellular signaling mechanisms regulating the activation of human eosinophils by the novel Th2 cytokine IL-33: implications for allergic inflammation | Q39026926 | ||
| IL-33 is upregulated in colonocytes of ulcerative colitis. | Q39929368 | ||
| Mast cells and eosinophils have a potential profibrogenic role in Crohn disease | Q40548817 | ||
| Development and validation of a pediatric Crohn's disease activity index | Q40749458 | ||
| Interleukin-33-dependent innate lymphoid cells mediate hepatic fibrosis | Q41945735 | ||
| IL-33 markedly activates murine eosinophils by an NF-κB-dependent mechanism differentially dependent upon an IL-4-driven autoinflammatory loop. | Q42935119 | ||
| Regulation of eotaxin-3/CC chemokine ligand 26 expression by T helper type 2 cytokines in human colonic myofibroblasts | Q44967205 | ||
| Esophageal remodeling in pediatric eosinophilic esophagitis | Q46304660 | ||
| IL-13 signaling via IL-13R alpha2 induces major downstream fibrogenic factors mediating fibrosis in chronic TNBS colitis | Q46306807 | ||
| Eosinophils alter colonic epithelial barrier function: role for major basic protein | Q46755349 | ||
| Mast cells infiltrate the esophageal smooth muscle in patients with eosinophilic esophagitis, express TGF-β1, and increase esophageal smooth muscle contraction | Q46969232 | ||
| Interleukin-5 participates in the pathogenesis of ileitis in SAMP1/Yit mice | Q47431206 | ||
| Human basophils interact with memory T cells to augment Th17 responses. | Q50932746 | ||
| Interleukin-33 expression is specifically enhanced in inflamed mucosa of ulcerative colitis. | Q54431742 | ||
| Eosinophils Express Functional IL-13 in Eosinophilic Inflammatory Diseases | Q61959803 | ||
| A new murine model of accelerated senescence | Q71011567 | ||
| Eosinophil granule-derived major basic protein induces IL-8 expression in human intestinal myofibroblasts | Q73023721 | ||
| Ablation of eosinophils leads to a reduction of allergen-induced pulmonary pathology | Q78396719 | ||
| Induction of IL-13 triggers TGF-beta1-dependent tissue fibrosis in chronic 2,4,6-trinitrobenzene sulfonic acid colitis | Q80178424 | ||
| Eosinophil-fibroblast interactions induce fibroblast IL-6 secretion and extracellular matrix gene expression: implications in fibrogenesis | Q81321357 | ||
| Characterization of the novel ST2/IL-33 system in patients with inflammatory bowel disease | Q82257596 | ||
| P433 | issue | 10 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 2429-2440 | |
| P577 | publication date | 2015-07-25 | |
| P1433 | published in | Inflammatory Bowel Diseases | Q15749161 |
| P1476 | title | Eosinophils and IL-33 Perpetuate Chronic Inflammation and Fibrosis in a Pediatric Population with Stricturing Crohn's Ileitis | |
| P478 | volume | 21 |
| Q89804518 | Clinical Implications of Pediatric Colonic Eosinophilia |
| Q42368405 | Editorial: Factors Promoting Development of Fibrosis in Crohn's Disease |
| Q99237529 | Eosinophilic Colitis and Clostridioides difficile Sepsis With Rapid Remission After Antimicrobial Treatment; A Rare Coincidence and Its Pathogenic Implications |
| Q92323510 | Eosinophils in the gastrointestinal tract and their role in the pathogenesis of major colorectal disorders |
| Q59804799 | Host Regulators of Liver Fibrosis During Human Schistosomiasis |
| Q39974669 | IL-33 Drives Eosinophil Infiltration and Pathogenic Type 2 Helper T-Cell Immune Responses Leading to Chronic Experimental Ileitis. |
| Q58566658 | IL-33/ST2 Axis in Organ Fibrosis |
| Q54240796 | ILC2s in infectious diseases and organ-specific fibrosis. |
| Q90385665 | Immunological roles of intestinal mesenchymal cells |
| Q26774652 | Macrophage and Innate Lymphoid Cell Interplay in the Genesis of Fibrosis |
| Q41273741 | The Role of Cytokines in the Fibrotic Responses in Crohn's Disease |
| Q90208339 | The emerging roles of eosinophils in mucosal homeostasis |
| Q40103784 | The orphan nuclear receptor RORα and group 3 innate lymphoid cells drive fibrosis in a mouse model of Crohn's disease |
| Q40074887 | Type 2 immunity in tissue repair and fibrosis |
| Q33711741 | Uncovering Pathogenic Mechanisms of Inflammatory Bowel Disease Using Mouse Models of Crohn's Disease-Like Ileitis: What is the Right Model? |
Search more.